Haw Par Corporation Limited HAWPF OTC · Healthcare · Singapore
$9.85 +0.00% +$0.00
Summary
68 / 100 · Bulios Score
What speaks for it
- Out of every 100 SGD of revenue, 104 SGD is left as net profit.
- Earnings per share grew by 21% a year over the last 3 years.
- It holds more cash than debt: $667.9M against $52.5M.
- The share price is below the Bulios Fair Price.
What to watch
- It earns only 1.3 SGD a year on every 100 SGD of invested capital.
- Revenue growth is slowing: 8.1% a year over the last 3 years against 16% over 5 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 12.2 SGD for 1 SGD of yearly profit. Over the last five years it was 14.1 SGD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (SGD)
Diluted EPS (SGD)
Revenue grew by 16% a year over 5 years. Over the last 3 years it grew by 8.1% a year. Earnings per share grew by 21% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 SGD of revenue goes
- Cost of sales 44 SGD
- Sales and administration 25 SGD
- Taxes and other -74 SGD
- Net profit 104 SGD
Net profit, industry median (Drug Manufacturers - General) 14 SGD
Out of every 100 SGD of revenue, 104 SGD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Moderate, safe- Yield
- 3.21%
- Paid out of profit
- 39%
- Raised in a row
- 3 years
You receive $0.32 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.